Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Precompetitive research: a new prescription for drug development?

Literature DB >> 20407454

Precompetitive research: a new prescription for drug development?

J Woodcock¹.

Abstract

Mesh：

Substances：

Year: 2010 PMID： 20407454 DOI： 10.1038/clpt.2010.28

Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Drug discovery in a multidimensional world: systems, patterns, and networks.

Authors: Joel T Dudley; Eric Schadt; Marina Sirota; Atul J Butte; Euan Ashley
Journal: J Cardiovasc Transl Res Date: 2010-07-31 Impact factor: 4.132

2. Intellectual property policies in early-phase research in public-private partnerships.

Authors: Hilde Stevens; Geertrui Van Overwalle; Bart Van Looy; Isabelle Huys
Journal: Nat Biotechnol Date: 2016-05-06 Impact factor: 54.908

3. Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

Authors: Adam Wanner; Stephen C Groft; J Russell Teagarden; Jeffrey Krischer; Barry R Davis; Christopher S Coffey; David H Hickam; Jeffrey Teckman; David R Nelson; Michael L McCaleb; Rohit Loomba; Charlie Strange; Robert A Sandhaus; Mark Brantly; Jonathan M Edelman; Albert Farrugia
Journal: Chronic Obstr Pulm Dis Date: 2015-04-28

4. Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies.

Authors: Rajiv Mahajan; Kapil Gupta
Journal: J Pharm Bioallied Sci Date: 2010-10

Precompetitive research: a new prescription for drug development?

1. Drug discovery in a multidimensional world: systems, patterns, and networks.

2. Intellectual property policies in early-phase research in public-private partnerships.

3. Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

4. Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies.

5. Where will the (New) Drugs for Traumatic Brain Injury Treatment be Coming From?

6. Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth.

7. Public-private partnerships as driving forces in the quest for innovative medicines.